title: The effect of electronegativity and angiotensin-converting enzyme inhibition on the kinin-forming capacity of polyacrylonitrile dialysis membranes.
abstract: The combination of negatively-charged membranes and angiotensin I-converting enzyme inhibitors (ACEi) evokes hypersensitivity reactions (HSR) during hemodialysis and bradykinin (BK)-related peptides have been hypothesized as being responsible for these complications. In this study, we tested the effects of neutralizing the membrane electronegativity (zeta potential) of polyacrylonitrile AN69 membranes by coating a polyethyleneimine layer (AN69-ST membranes) over the generation of kinins induced by blood contact with synthetic membranes. We used minidialyzers with AN69 or AN69-ST membranes in an ex vivo model of plasma and we showed that plasma dialysis with AN69 membranes led to significant BK and des-Arg(9)-BK release, which was potentiated by ACEi. This kinin formation was dramatically decreased by AN69-ST membranes, even in the presence of an ACEi, and kinin recovery in the dialysates was also significantly lower with these membranes. High molecular weight kininogen and factor XII detection by immunoblotting of the protein layer coating both membranes corroborated the results: binding of these proteins and contact system activation on AN69-ST membranes were reduced. This ex vivo experimental model applied to the plasma, dialysate and dialysis membrane could be used for the characterization of the kinin-forming capacity of any biomaterial potentially used in vivo in combination with drugs which modulate the pharmacological activity of kinins.
authors: Faculty of Pharmacy, Université de Montréal, Montréal, Québec, Canada.
authors: Anik
authors: A
authors: Désormeaux
authors: Marie Eve
authors: ME
authors: Moreau
authors: Yves
authors: Y
authors: Lepage
authors: Jacques
authors: J
authors: Chanard
authors: Albert
authors: A
authors: Adam
mesh_terms: D000180:Acrylic Resins / Q000009:adverse effects; D000181:Acrylonitrile / Q000009:adverse effects / Q000031:analogs & derivatives*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology*; D001920:Bradykinin / Q000031:analogs & derivatives / Q000097:blood; D004563:Electrochemistry; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D007705:Kinins / Q000097:blood*; D008297:Male; D008422:Materials Testing; D008564:Membrane Potentials; D008567:Membranes, Artificial; D006435:Renal Dialysis / Q000009:adverse effects / Q000295:instrumentation*
chemical_list: D000180:Acrylic Resins; D000806:Angiotensin-Converting Enzyme Inhibitors; D007705:Kinins; D008567:Membranes, Artificial; C024626:bradykinin, des-Arg(9)-; C016892:AN-69; D000181:Acrylonitrile; D001920:Bradykinin